Population pharmacokinetic modeling of pyrazinamide in children and adults with tuberculosis.

Study Objective: To determine population pharmacokinetic parameters of pyrazinamide after multiple oral doses given to children and adults with tuberculosis.

Design: Prospective, multiple-dose population pharmacokinetic study.

Setting: Five hospitals in the United States.